Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors

Histone deacetylase inhibitors (HDACi) have modest objective response rates ranging from 5.5% to 49% [1–5] as single agents. Furthermore, HDACi exert their anti-tumor effects in different ways, lik...